FDA Approves RHA Redensity Eye for Infraorbital Volume Deficiencies
FDA approves RHA Redensity Eye for correction of moderate to severe tissue volume deficiencies in the infraorbital region in adults ages 22 and older.
Search fresh public links, source activity, and ready-to-use post angles for Teoxane.
Fresh curated links around teoxane are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
FDA approves RHA Redensity Eye for correction of moderate to severe tissue volume deficiencies in the infraorbital region in adults ages 22 and older.
The hyaluronic acid gel is designed to mimic bone for lower face shaping and uses a new technology to provide firmness.
The treatment is the first short-duration facial injectable available in the region for the temporary improvement of lines between the eyebrows.
Following notified body confirmation, the company is continuing the rollout of its full Microthane portfolio, available in both standard EasyFit and lightweight B-Lite gel options.
The licensing and distribution agreement expands the company's injectable portfolio into the skin quality category.
FACTOR X is a newly launched longevity-focused beauty technology company developing a breakthrough cellular delivery platform designed to transform the anti-aging skincare industry...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.